Plasma malondialdehyde (MDA) levels in breast and lung cancer patients

Gonenc A., Ozkan Y., Torun M., Simsek B.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, cilt.26, sa.2, ss.141-144, 2001 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 2
  • Basım Tarihi: 2001
  • Doi Numarası: 10.1046/j.1365-2710.2001.00334.x
  • Dergi Adı: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.141-144
  • Anahtar Kelimeler: breast cancer, lipid peroxidation, lung cancer, malondialdehyde (MDA), LIPID-PEROXIDATION, MAMMOGRAPHIC DYSPLASIA, ANTIOXIDANT FUNCTIONS, PREMENOPAUSAL WOMEN, SERUM-CHOLESTEROL, BETA-CAROTENE, VITAMIN-C
  • Gazi Üniversitesi Adresli: Evet

Özet

Objective: To measure the levels of malondialdehyde (MDA), a marker of lipid peroxidation, in patients with breast and lung cancer.